Skip to main content
Erschienen in: Child's Nervous System 12/2008

01.12.2008 | Case-based Update

Malignant glioblastomatous transformation of a low-grade glioma in a child

verfasst von: Ekrem Unal, Yavuz Koksal, Omer Cimen, Yahya Paksoy, Lema Tavli

Erschienen in: Child's Nervous System | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The term of low-grade glioma addresses a favorable clinical outcome with indolent histological features in general consideration; however, recent studies underline the inconsistency, which originates from the accumulation of different histologic subtypes in this terminology. The malignant transformation of a low-grade glioma is unusual but presents a poor prognosis.

Case history

We report a case of a 12-year-old boy, who was referred for complaints of recurrent seizures. His physical examination was unremarkable, but it was learned that a peripheral mass lesion located on the left posterior parietal lobe—which had been thought to be a low-grade glioma—had been detected on a magnetic resonance imaging 2 years ago at a different hospital. The patient was then treated with valproate and carbamazepine for the seizures and advised to be followed up without any additional diagnostic and therapeutic studies for his suspected low-grade glioma. A recent magnetic resonance imaging study showed enlargements of the mass and surrounding edema with additional necrosis. Surgical excision of the tumor was performed. After the diagnosis of glioblastoma multiforme, the patient received radiation therapy and chemotherapy with a good clinical recovery without any evidence of residue or recurrence at 12-month follow-up.

Conclusion

The first line treatment modality in the management of low-grade glioma—especially in suitable patients—is clearly surgery. The gross total resection guarantees the distinguishing of the histological types of the low-grade gliomas and reflects the biologic behavior of these tumors. Observation without surgery must be reserved for selected unoperable cases.
Literatur
1.
Zurück zum Zitat Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M, Dalton J, Zambetti GP, Ellison DW, Kun LE, Gajjar A, Gilbertson RJ, Fuller CE (2006) Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25:682–629CrossRef Broniscer A, Baker SJ, West AN, Fraser MM, Proko E, Kocak M, Dalton J, Zambetti GP, Ellison DW, Kun LE, Gajjar A, Gilbertson RJ, Fuller CE (2006) Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol 25:682–629CrossRef
2.
Zurück zum Zitat Perry A (2003) Pathology of low-grade gliomas: an update of emerging concepts. Neurooncology 5:168–178 Perry A (2003) Pathology of low-grade gliomas: an update of emerging concepts. Neurooncology 5:168–178
3.
Zurück zum Zitat Pouratian N, Asthagiri A, Jagannathan J, Shaffrey ME, Schiff D (2007) Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol 3:628–639PubMedCrossRef Pouratian N, Asthagiri A, Jagannathan J, Shaffrey ME, Schiff D (2007) Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol 3:628–639PubMedCrossRef
4.
Zurück zum Zitat Kocaeli H, Yakut T, Bekar A, Taşkapilioğlu O, Tolunay S (2006) Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report. Surg Neurol 66:627–631PubMedCrossRef Kocaeli H, Yakut T, Bekar A, Taşkapilioğlu O, Tolunay S (2006) Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report. Surg Neurol 66:627–631PubMedCrossRef
5.
Zurück zum Zitat Jay V, Squire J, Becker LE, Humphreys R (1994) Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis. Cancer 73:2862–2868PubMedCrossRef Jay V, Squire J, Becker LE, Humphreys R (1994) Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis. Cancer 73:2862–2868PubMedCrossRef
6.
Zurück zum Zitat Mittelbronn M, Schittenhelm J, Lemke D, Ritz R, Nägele T, Weller M, Meyermann R, Beschorner R (2007) Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components. Neuropathology 27:463–467PubMedCrossRef Mittelbronn M, Schittenhelm J, Lemke D, Ritz R, Nägele T, Weller M, Meyermann R, Beschorner R (2007) Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components. Neuropathology 27:463–467PubMedCrossRef
7.
Zurück zum Zitat Kim NR, Wang KC, Bang JS, Choe G, Park Y, Kim SK, Cho BK, Chi JG (2003) Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis. Pathol Int 53:874–882PubMedCrossRef Kim NR, Wang KC, Bang JS, Choe G, Park Y, Kim SK, Cho BK, Chi JG (2003) Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis. Pathol Int 53:874–882PubMedCrossRef
8.
Zurück zum Zitat Rumana CS, Valadka AB (1998) Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery 42:1038–1043PubMedCrossRef Rumana CS, Valadka AB (1998) Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery 42:1038–1043PubMedCrossRef
10.
Zurück zum Zitat Tarnaris A, O'Brien C, Redfern RM (2006) Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy. Clin Neurol Neurosurg 108:761–767PubMedCrossRef Tarnaris A, O'Brien C, Redfern RM (2006) Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy. Clin Neurol Neurosurg 108:761–767PubMedCrossRef
11.
Zurück zum Zitat Unal E, Koksal Y, Vajtai I, Toy H, Kocaogullar Y, Paksoy Y (2008) Astroblastoma in a child. Childs Nerv Syst 24:165–168PubMedCrossRef Unal E, Koksal Y, Vajtai I, Toy H, Kocaogullar Y, Paksoy Y (2008) Astroblastoma in a child. Childs Nerv Syst 24:165–168PubMedCrossRef
12.
Zurück zum Zitat Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20:E1PubMedCrossRef Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20:E1PubMedCrossRef
13.
Zurück zum Zitat McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults—1977–1988. Neurosurgery 31:636–642PubMedCrossRef McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults—1977–1988. Neurosurgery 31:636–642PubMedCrossRef
14.
Zurück zum Zitat Cairncross JG, Laperriere NJ (1989) Low-grade glioma. To treat or not to treat? Arch Neurol 46:1238–1239PubMed Cairncross JG, Laperriere NJ (1989) Low-grade glioma. To treat or not to treat? Arch Neurol 46:1238–1239PubMed
15.
Zurück zum Zitat Cavaliere R, Lopes MB, Schiff D (2005) Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760–770PubMedCrossRef Cavaliere R, Lopes MB, Schiff D (2005) Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760–770PubMedCrossRef
16.
Zurück zum Zitat Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533–536PubMed Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533–536PubMed
17.
Zurück zum Zitat Jenkinson MD, Smith TS, Brodbelt AR, Joyce KA, Warnke PC, Walker C (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412PubMedCrossRef Jenkinson MD, Smith TS, Brodbelt AR, Joyce KA, Warnke PC, Walker C (2007) Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 26:1405–1412PubMedCrossRef
18.
Zurück zum Zitat Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S (2005) High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 60:493–502PubMedCrossRef Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S (2005) High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 60:493–502PubMedCrossRef
19.
Zurück zum Zitat Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745PubMedCrossRef Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745PubMedCrossRef
20.
Zurück zum Zitat van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB, EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990PubMedCrossRef van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB, EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990PubMedCrossRef
21.
Zurück zum Zitat Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM (2007) Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49:808–811PubMedCrossRef Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM (2007) Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49:808–811PubMedCrossRef
Metadaten
Titel
Malignant glioblastomatous transformation of a low-grade glioma in a child
verfasst von
Ekrem Unal
Yavuz Koksal
Omer Cimen
Yahya Paksoy
Lema Tavli
Publikationsdatum
01.12.2008
Verlag
Springer-Verlag
Erschienen in
Child's Nervous System / Ausgabe 12/2008
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-008-0716-3

Weitere Artikel der Ausgabe 12/2008

Child's Nervous System 12/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.